Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapy

Fig. 5

The correlation of CCL19 concentration with clinical characteristics and survival outcomes in CHCAMS cohort. Concentration of serum CCL19 among difference age groups (A), different FLIPI groups (B) and different rituximab maintenance groups (C). Kaplan–Meier curves of CCL19 concentration with D progression-free survival and E overall survival. FLIPI: Follicular Lymphoma International Prognostic Index; PFS: progression-free survival; OS: overall survival

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us